58.89 USD
↗ 2.97 (5.31%)AT CLOSE (11:59 AM EDT)
Vaxcyte, Inc. Common Stock
PCVXNASDAQ • USD
58.64
↘ 0.25 (0.42%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
58.64
↘ 0.25 (0.42%)
Market: CLOSED
Shares of Vaxcyte, Inc. Common Stock (PCVX) are trading at $58.95. PCVX shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, PCVX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 6, 2026.
Open?$55.17
High?$59.00
Low?$54.71
Prev. Close?$55.92
Volume?1.3M
Avg. Volume?1.5M
VWAP?$58.15
Rel. Volume?0.88x
Bid / Ask
Bid?$50.00 × 100
Ask?$59.15 × 100
Spread?$9.15
Midpoint?$54.58
Valuation & Ratios
Market Cap?8.1B
Shares Out?144.4M
Float?126.8M
Float %?87.8%
P/E Ratio?N/A
P/B Ratio?2.70
EPS?-$6.56
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Employees
507
Market Cap
8.1B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-06-12
Address
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS, CA 94070
Phone: 650-837-0111
SAN CARLOS, CA 94070
Phone: 650-837-0111
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?38
Piotroski F-Score?0/9Weak
Altman Z-Score?12.21Safe
Confidence?49%Low
Short InterestVery High
Short % of Float?11.22%High
Short Interest?14.2M
Days to Cover?12.4
Free Float126.8M
Avg Daily Volume1.2M
Settlement Date2026-07-15
Financial Health
Current Ratio?7.49Strong
Quick Ratio?7.49Strong
Cash Ratio?1.08Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.70CHEAP▾
Peers100
S&P61
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-31.6%WEAK▾
S&P6
ROA?-28.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-814944000
Enterprise Value?$7.8B
Fundamentals ratios updated end of day